EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ApoE4 as a Therapeutic Target in Epilepsy: From Pathogenic Mechanisms to Precision Medicine

Kang Pan, Keyi Zhu, Yajun E, Yucang He iD, Siqi Ding iD

CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)

DOI: 10.1002/cns.71167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 22.09.2026. Verfasst von Kang Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China. Hauptthemen laut MEDLINE: Epilepsy, Apolipoprotein E4, Precision Medicine. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, the Major (Key) Science and Technology Project of Jinhua City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy is a heterogeneous central nervous system disorder characterized by recurrent seizures and is frequently accompanied by cognitive and neuropsychiatric comorbidities. Although apolipoprotein E4 (ApoE4) is well established as a genetic risk factor in Alzheimer's disease, its role as a modifier of epilepsy susceptibility, progression, and therapeutic response remains incompletely understood.

Objective

This review aims to summarize current evidence regarding the molecular mechanisms, clinical implications, and therapeutic potential of ApoE4 in epilepsy, with emphasis on its relevance to precision medicine.

Methods

A narrative review was conducted by synthesizing preclinical and clinical studies investigating the relationship between ApoE4 and epilepsy, including mechanisms related to neuroinflammation, synaptic dysfunction, lipid metabolism, blood–brain barrier (BBB) integrity, clinical phenotypes, and targeted therapeutic strategies.

Results

ApoE4 contributes to epileptogenesis through multiple interconnected pathways. It promotes neuroinflammatory responses by activating microglia and inflammatory signaling, disrupts synaptic plasticity through N‐methyl‐D‐aspartate receptor dysfunction and excitation‐inhibition imbalance, impairs lipid and energy metabolism leading to neuronal hyperexcitability, and compromises BBB integrity. Clinically, ApoE4 carriers show increased seizure susceptibility, accelerated cognitive decline, hippocampal atrophy, and variable responsiveness to antiseizure medications. Emerging therapeutic approaches include ApoE4 structural correction, modulation of metabolic and inflammatory pathways, and gene‐based interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyApolipoprotein E4Precision MedicineHumansAnimalsBlood-Brain BarrierNeuroinflammatory DiseasesAnticonvulsants

Stichwörter der Autor:innen

apolipoprotein E4epilepsyneuroinflammationprecision medicine

Substanzen

Apolipoprotein E4Anticonvulsants

Autor:innen und Institutionen

  • Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
  • The Affiliated Yiwu Hospital of Wenzhou Medical University, Yiwu City, Zhejiang Province, People's Republic of China.
  • First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, People's Republic of China.

ORCID-Profile: Yucang He, Siqi Ding

Förderung

  • Natural Science Foundation of Zhejiang Province
  • the Major (Key) Science and Technology Project of Jinhua City

Zitieren

APA

Pan, K., Zhu, K., E, Y., He, Y., & Ding, S. (2026). ApoE4 as a Therapeutic Target in Epilepsy: From Pathogenic Mechanisms to Precision Medicine. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71167

Vancouver

Pan K, Zhu K, E Y, He Y, Ding S. ApoE4 as a Therapeutic Target in Epilepsy: From Pathogenic Mechanisms to Precision Medicine. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71167

BibTeX
@article{Pan2026,
  author = {Pan, Kang and Zhu, Keyi and E, Yajun and He, Yucang and Ding, Siqi},
  title = {ApoE4 as a Therapeutic Target in Epilepsy: From Pathogenic Mechanisms to Precision Medicine},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {9},
  doi = {10.1002/cns.71167}
}
Kostenlos starten →